Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix

Veterinary Surgery

Volumn 33, Issue 2, 2004, Pages 112-118

  Schmökel, Hugo G ^a   Weber, Franz E ^b   Seiler, Gabriela ^b   Von Rechenberg, Brigitte ^b   Schense, Jason C ^b   Schawalder, Peter ^b   Hubbell, Jeffrey ^b  

^a Division of Small Animal Surgery   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; FIBRIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE PROSTHESIS; CAT; DOG; EVALUATION; FEMALE; FEMUR FRACTURE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; INJURY; MALE; METACARPAL BONE; METHODOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RADIUS FRACTURE; RAT; SPRAGUE DAWLEY RAT; TIBIA FRACTURE; TREATMENT OUTCOME;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; CATS; DOGS; FEMALE; FEMORAL FRACTURES; FIBRIN; FRACTURE FIXATION; FRACTURE HEALING; FRACTURES, UNUNITED; MALE; METACARPUS; PROSPECTIVE STUDIES; RADIUS FRACTURES; RATS; RATS, SPRAGUE-DAWLEY; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 2442663178     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950x.2004.04018.x     Document Type: Article

References (26)

1. Kirker-Head CA: Recombinant bone morphogenetic proteins: Novel substances for enhancing bone healing. Vet Surg 24:408-419, 1995
2. Summer-Smith G: Delayed unions and nonunions. Fracture Complications. Philadelphia, PA, WB Saunders. Vet Clin North Am: Small Anim Pract 21, 1991, 745-760
3. Balzer AW, Liebau CH: Bone morphogenetic proteins - Bedeutung für die biologische Knochenheilung. Z Orthop 137:9-10, 1999
4. Brekke JH, Toth JM: Principles of tissue engineering applied to programmable osteogenesis. J Biomed Mat Res 43: 365-373, 1998
5. Sampath TK, Ozkaynak E, Wolfe MW et al: Recombinant human osteogenic protein (hOP-1) induces new bone formation with a specific activity comparable to that of natural bone OP. Transactions of the 38th Annual Orthopaedic Research Society, 1992, 72pp.
6. Miyamoto S, Takaoka K, Hashimoto J, et al: A new synthetic biodegradable polymer suitable as a carrier for bone morphogenetic protein. Clin Orthop 294:329-36, 1993
7. Schmoekel H, Schense JC, Weber FE, et al: Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res (in press)
8. Weber FE, Eyrich G, Grätz KW, et al: Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification. Biochem Biophys Res Commun 286:554-8, 2001
9. Weber FE, Eyrich G, Grätz KW, et al: Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foam-spheres. Int J Oral Maxillofac Surg 31:60-65, 2002
10. Liptak JM, Vogelnest L, Shimmin AJ, et al: Use ofosteogenic protein-1 in the management of a nonunion radial fracture in a squirrel monkey. Vet Comp Orthop Traumatol 14:165-168, 2001
11. Hollinger J: Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 43:356-364, 1998
12. Yasko AW, Lane JM, Fellinger EJ, et al: The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2): A radiographic, histological and biomechanical study in rats. J Bone Joint Surg 74:659-670, 1992
13. Isobe M, Yamazaki Y, Mori M, et al: Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2. J Oral Maxillifac Surg 57:695-98, 1999
14. Lee SC, Shea M, Battle MA, et al: Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix. J Biomed Mat Res 28:1149-56, 1994
15. Ohura K, Hamanishi C, Tanaka S, et al: Healing of segmental bone defects in rats induced by a β-TCP-MCPM cement combined with rhBMP-2. J Biomed Mater Res 44:168-75, 1999
16. Mason DR, Renberg WC: Postsurgical enhancement of fracture repair: Biologic alternatives to bone grafting. Compendium Small Anim 23:72-278, 2001
17. Hauschild G, Meyer-Lindenberg A, Fehr M: Plättchenreiches Plasma plus phasenreines b-Tricalciumphosphat - ein neuartiges Konzept des Knochenersatzes. Kleintierpraxis 45:909-917, 2000
18. Toriumi DM, Kotler HS, Luxenberg DP, et al: Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg 117:1101-1112, 1991
19. Gerhart TN, Kirker-Head CA, Henning GE, et al: Healing segmental femoral defects in sheep using recombinant human morphogenetic protein (BMP2). Clin Orthop 293:317-326, 1993
20. Cook SD, Salkeld SL, Brinker MR, et al: Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma 12:407-412, 1998
21. Den Boer FC, Bramer JAM, Blokhuis TJ, et al: Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. Bone 31:158-64, 2002
22. Bruder SP, Fox BS: Tissue engineering of bone. Clin Orthop 3675:86-93, 1999
23. Pittman RN, Buettner HM: Degradation of extracellular matrix by neuronal proteases. Dev Neuro 11:361-375, 1989
24. Herbert CB, Bittner GD, Hubbell JA: Effects of fibrinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J Compar Neuro 365:380-391, 1996
25. Yamagucchi A, Katagiri T, Ikeda T, et al: Recombinant human bone morphogentic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentation in vitro. J Cell Biol 113:681-687, 1991
26. Katagiri T, Yamagucchi A, Ikeda T, et al: The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299, 1990